1. Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12
   Irene del Molino del Barrio et al, 2018, International Journal of Molecular Sciences CrossRef
2. MicroRNA-126 is downregulated in thyroid cancer cells, and regulates proliferation, migration and invasion by targeting CXCR4
   YAN QIAN et al, 2016, Molecular Medicine Reports CrossRef
3. Germline stem cells in human
   Hanhua Cheng et al, 2022, Signal Transduction and Targeted Therapy CrossRef
4. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme
   Simona Daniele et al, 2021, European Journal of Pharmacology CrossRef
5. LY333531, a PKCβ inhibitor, attenuates glomerular endothelial cell apoptosis in the early stage of mouse diabetic nephropathy via down-regulating swiprosin-1
   Zhi-bin Wang et al, 2017, Acta Pharmacologica Sinica CrossRef
6. The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy
   Yu ZHOU et al, 2018, Chinese Journal of Natural Medicines CrossRef
7. RTN3 Regulates the Expression Level of Chemokine Receptor CXCR4 and is Required for Migration of Primordial Germ Cells
   Haitao Li et al, 2016, International Journal of Molecular Sciences CrossRef
8. Role of chemokine systems in cancer and inflammatory diseases
   Hongyi Li et al, 2022, MedComm CrossRef
9. The autocrine CXCR4/CXCL12 axis contributes to lung fibrosis through modulation of lung fibroblast activity
   Fei Li et al, 2020, Experimental and Therapeutic Medicine CrossRef